Similar articles

Abstract: There is a paucity of data regarding trends in the incidence of heart disease in China during recent years. Using a large echocardiography database in our center, we analyzed trends in the prevalence of several common heart diseases from Dec. 2003. This study retrospectively analyzed the echocardiographic database in our Department from 2003 to 2012. A total of 385 682 cases were included in the study. The prevalence of rheumatic heart disease decreased over the 10-year period, from 4.04% in 2003 to 3.06% in 2012 (P<0.01). Infective endocarditis also decreased, from a mean prevalence of 0.37% in July 2003 to 0.27% in Dec. 2008 (P<0.001). The prevalence of hypertrophic cardiomyopathy, which includes 20% apical hypertrophic cardiomyopathy and 20% hypertrophic obstructive cardiomyopathy, was about 1.8%. The prevalence of the three most common adult congenital heart diseases (CHDs) decreased by about 10% from July 2003 to Dec. 2008 (all P<0.001). The prevalence of moderate pulmonary arterial hypertension (PAH) or left ventricular systolic dysfunction (LVSD) decreased during the 10-year period (P<0.001), but there was no change in the prevalence of severe PAH or LVSD (P>0.05). The present study indirectly demonstrates that the prevalence of several common heart diseases in China has declined in recent years.

从单中心大型超声心动图数据分析近十年中国 心脏疾病患病率的变化趋势

[1]Douglas, P.S., Garcia, M.J., Haines, D.E., et al., 2011. Appropriate use criteria for echocardiography. J. Am. Soc. Echocardiogr., 24(3):229-267.

[2]Chen, H.Z., Fan, W.H., Jin, X.J., et al., 2003. Changing trends of etiologic characteristics of cardiovascular diseases among inpatients in Shanghai: a retrospective observational study from 1948 to 1999. Chin. J. Intern. Med., 42(12):829-832 (in Chinese).

[3]Eriksson, M.J., Sonnenberg, B., Woo, A., et al., 2002. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., 39(4):638-645.

[4]He, J., Gu, D., Wu, X., et al., 2005. Major causes of death among men and women in China. N. Engl. J. Med., 353(11):1124-1134.

[5]Li, J., Li, X., Wang, Q., et al., 2014. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet, 385(9966):441-451.

[6]Maron, B.J., Gardin, J.M., Flack, J.M., et al., 1995. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation, 92(4):785-789.

[7]Mitchell, S.C., Korones, S.B., Berendes, H.W., 1971. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation, 43(3):323-332.

[8]Moro, E., D'Angelo, G., Nicolosi, G.L., et al., 1995. Long-term evaluation of patients with apical hypertrophic cardiomyopathy. Correlation between quantitative echocardiographic assessment of apical hypertrophy and clinical-electrocardiographic findings. Eur. Heart J., 16(2):210-217.

[9]NCCD (National Center for Cardiovascular Disease of China), 2010. Report on Cardiovascular Disease in China (2008– 2009). Encyclopedia of China Publishing House, p.7 (in Chinese).

[10]Sakamoto, T., Tei, C., Murayama, M., et al., 1976. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn. Heart J., 17(5):611-629.

[11]Warnes, C.A., Liberthson, R., Danielson, G.K., et al., 2001. Task force 1: the changing profile of congenital heart disease in adult life. J. Am. Coll. Cardiol., 37(5):1170-1175.

[12]Wigle, E.D., Sasson, Z., Henderson, M.A., et al., 1985. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Prog. Cardiovasc. Dis., 28(1):1-83.

[13]World Health Organization, 2005. Preventing chronic diseases: a vital investment. Available from http://www.who.int/chp/chronic_disease_report/full_report.pdf [Accessed on Apr. 10, 2015].

[14]World Health Organization, 2009. World health statistics 2009. Geneva: World Health Organization. Available from http://www.who.int/whosis/whostat/EN_WHS09_Full.pdf [Accessed on Apr. 10, 2015].

[15]Yang, G., Kong, L., Zhao, W., et al., 2008. Emergence of chronic non-communicable diseases in China. Lancet, 372(9650):1697-1705.

[16]Yang, X.Y., Li, X.F., Lü, X.D., et al., 2009. Incidence of congenital heart disease in Beijing, China. Chin. Med. J. (Engl.), 122(10):1128-11132.

[17]Wang, Z.M., Zou, Y.B., Song, L., et al., 2006. Prevalence of chronic rheumatic heart disease in Chinese adults. Int. J. Cardiol., 107(3):356-359.

[18]Zoghbi, W.A., Enriquez-Sarano, M., Foster, E., et al., 2003. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J. Am. Soc. Echocardiogr., 16(7):777-802.

[19]Zou, Y., Song, L., Wang, Z., et al., 2004. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am. J. Med., 116(1):14-18.